Department
Cezar Darwiche FY1
Asthma
Chronic inflammatory disease of the
airways
Episodic cough, wheezing, dyspnea
Type I hypersensitivity reaction (Ag cross
links IgE on pre-sensitized mast cells and basophils triggering release of vasoactive amines) Types
•
•
•
•
Extrinsic
- Onset in childhood
-Triggered by inhaled allergen exposure:
Dust mites
Cockroaches
Cat antigen
Molds and pollens
Types
Intrinsic
Early adulthood
• Triggered by viral infections, nonspecific irritants • Obesity risk factor
•
Types
Exercise-induced
Bronchospasm lasting 10-20 mins after exercise • Triggered by drying/ cooling of airways
• Requires prophylaxis
•
Types
Triad Asthma
Samter’s Syndrome …show more content…
• Asthma
• Nasal polyps
• Aspirin or NSAID sensitivity
•
Types
Cough-variant asthma
May present with cough in absence of wheezing • One of the 3 most common causes of chronic cough (GERD, postnasal drip)
•
Types
Occupational asthma
“Monday morning” symptoms which abate during weekends
• Worse in the evening after work
• Commonly epoxy resins, plastics and rubber, metals, lab animals
•
Types
•
•
•
•
•
•
•
•
Refractory asthma
Chronic unremitting
Chronic exposure
B-blockers (even Timolol eye drops)
Aspirin containing drugs
GERD
Fungal infections
ABPA
Churg-strauss
Types
•
•
•
•
•
•
•
Disorders that mimic asthma
Congestive heart failure
Mitral stenosis
Laryngeal tumors
Subglottic stenosis
Wegener’s
Vocal cord dysfunction
Left atrial enlargement with vagus impingement
Diagnosis
History of wheezing with specific triggers
Obstructive lung disease on PFTs that
normalize when asymptomatic
DLCO normal between episodes
Negative Methacoline challenge test effectively rules out asthma
Treatment
Goals
Avoid symptoms
• Minimize use of short-acting bronchodilators • Prevent nocturnal awakening
• Minimize side-effects
•
Treatment
Four components
Monitor symptoms and pulmonary function
• Control environmental exposures
• Educate patient on trigger avoidance and treament • Drugs
•
Emergency management
Acute severe asthma
Peak flow (PEF) 33-50% best or predicted
• RR>25/min
• HR>110/min
• Inability to complete sentences in 1 breath
•
Emergency management
•
•
•
•
•
•
•
•
Life threatening asthma
Peak flow (PEF) <33% best or predicted
SaO2 <92% paO2 <60mmHg
PH <7.35
Silent chest
Cyanosis
Bradycardia, arrthymia, hypotension
Confusion, coma
Emergency management
•
•
•
•
•
Management
Sit patient up (beware COPD exacerbation)
High flow O2 (100% non-rebreathing)
High dose nebulized B2 agonist (salbutamol
5mg or terbutaline 10mg)
WITH nebulized anticholinergic (Ipratropium
Bromide 0.5mg) for acute severe or life threatening Here given as Combivent
Emergency management
Management
Corticosteroids
• Prednisolone 40-60mg PO
• Or Hydrocortisone 100mg IV
• Consider IV Aminophylline if poor response •
Emergency management
Obtain CXR if:
•
•
•
•
•
Suspected pneumothorax
Suspected consolidation
Life-threatening asthma
Failure to respond satisfactorily
Requirement for ventilation
Emergency management
If improving
40-60% O2
• prednisolone 40-50mg/ 24hrs PO
• Nebulized salbutamol every 4hrs
• Monitor peak flow
•
Emergency management
If not improving after 15mins
Continue 100% O2
• Repeat steroids
• Salbutamol nebulizers every 15min or
10mg continuous per hour
• Ipratropium 0.5mg every 4-6hrs
•
Emergency management
If patient still not improving at >30mins
Consider MgSO4 1.2-2g IV over 20mins
• Aminophylline IV
• Transfer to ICU for ventilation
•
Emergency management
Monitoring
Repeat PEF 15-30mins after treatment
• Pulse oximetry monitoring maintain SaO2
>92%
• ABG within 2hrs if initial PaCO2 was normal/raised or initial PaO2 <60mmHg
• Record PEF pre and post B2 agonist in hospital at least 4 times
•
Emergency management
Patient has improved
Stop Aminophylline over 12-24hrs
• Reduce nebulized Salbutamol and switch to inhaled B2 agonist
• Stop oral steroids and initiate inhaled
• Monitor PEF
•
Emergency management
Cardiac Arrest in Acute severe ashtma
Usually PEA
Due to :
• Prolonged severe hypoxia
• Hypoxia related arrythmia
• Tension pneumothorax
• Acidosis and hyperkalemia
• Follow ACLS guidelines
•